Cortex Medipharma Private Limited - Company Profile

It is a pharma private limited company based in Bengaluru, Karnataka, India, established in 2011.
2011 Bengaluru, Karnataka, India Active
Last Updated:
Access Report
About Cortex Medipharma Private Limited

Cortex Medipharma Private Limited, a active private limited company, was established on 03 March 2011 in Bengaluru, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74990KA2011PTC057346. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.20 M.

It upholds a compliant status. Its leadership includes Nagaraj Dharanendra Vardhaman (Director), Manjula Nagaraj Vardhaman (Director). Past directors included Kashinath Guranna Marnoor, Bheemashankar Bhooprao Sadalapur, Santosh Chinchure. Its latest AGM occurred on 03 January 2022, with the balance sheet filed on 31 March 2021. It is based at Shop No 2 No 314 6Th Cross 40 Feet Main Road Pramod Layout Pantarpalya Rajarajeshwar, I Nagar, Bengaluru, Karnataka, 560039.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74990KA2011PTC057346

  • Registration Number

    057346

  • Incorporation Date

    03 March 2011

  • Authorized Capital

    ₹0.20 M

  • Paid-Up Capital

    ₹0.20 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.20 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 15 Year, 17 Days
  • Last Filing with ROC 31 Mar 2021
  • Revenue Growth **** -17.66%
  • Profit Growth **** 86.14%
  • Ebitda **** 93.99%
  • Net Worth 14.30%
  • Total Assets **** 13.66%
Company report

Cortex Medipharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Cortex Medipharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Cortex Medipharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Nagaraj Dharanendra Vardhaman Director 03 Mar 2011 Current
Manjula Nagaraj Vardhaman Director 22 Mar 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 23 Dec 2016 Past
Pramod Abcsdd Director 26 Feb 2015 Past
Pramod Abcsdd Director 22 Mar 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cortex Medipharma.

Cortex Medipharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 17.66% decrease. The company also saw a substantial improvement in profitability, with a 86.14% increase in profit. The company's net worth Soared by an impressive increase of 14.3%.

Cortex Medipharma revenue growth over time
Cortex Medipharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -17.66%
*******
*******
*******
*******
Revenue from Operations
*******
 -17.66%
*******
*******
*******
*******
Total Assets
*******
 13.66%
*******
*******
*******
*******
Profit or Loss
*******
 86.14%
*******
*******
*******
*******
Net Worth
*******
 14.30%
*******
*******
*******
*******
EBITDA
*******
 93.99%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cortex Medipharma?

In 2021, Cortex Medipharma had a promoter holding of 96.00% and a public holding of 4.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Cortex Medipharma?

Unlock and access historical data on people associated with Cortex Medipharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cortex Medipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cortex Medipharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cortex Medipharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Cortex Medipharma Private Limited last Annual general meeting of members was held on 03 Jan 2022 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Cortex Medipharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Bangalore. was completed.

  • Director Appointment

    Progress on Manjula Nagaraj Vardhaman was appointed as a Director was appointed as a Director on 22 Mar 2017 & has been associated with this company since 8 years 11 months . was documented.

  • Director Appointment

    Progress on Nagaraj Dharanendra Vardhaman was appointed as a Director was appointed as a Director on 03 Mar 2011 & has been associated with this company since 15 years 17 days . was documented.

  • Company Incorporation

    Progress on Cortex Medipharma Private Limited was registered on 03 Mar 2011 with Roc Bangalore & aged 15 years 17 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cortex Medipharma Private Limited?

The CIN of Cortex Medipharma Private Limited is U74990KA2011PTC057346.

Where is Cortex Medipharma Private Limited headquartered?

Cortex Medipharma Private Limited is headquartered at Shop No 2 No 314 6Th Cross 40 Feet Main Road Pramod Layout Pantarpalya Rajarajeshwar, I Nagar, Bengaluru, Karnataka, 560039.

When was Cortex Medipharma Private Limited incorporated?

Cortex Medipharma Private Limited was incorporated on 03 March 2011.

Who are the current directors of Cortex Medipharma Private Limited?

The current directors of Cortex Medipharma Private Limited are

What is the primary industry of Cortex Medipharma Private Limited?

The primary industry of Cortex Medipharma Private Limited is Trade.

Is Cortex Medipharma Private Limited a listed company?

Cortex Medipharma Private Limited is unlisted.

What is the capital structure of Cortex Medipharma Private Limited?

The authorized capital of Cortex Medipharma Private Limited is ₹0.20 M, and the paid-up capital is ₹0.20 M.

What is the compliance status of Cortex Medipharma Private Limited?

The compliance status of Cortex Medipharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available